Tpp47 is one of the major antigenic components of the bacterium Treponema pallidum. It triggers an early humoral response three to six days after infection. The Tpp47 antigen has been reported as a potential market for active syphilis disease, as anti-Tpp47 IgM have been detected in patients with congenital syphilis.
FOR RESEARCH ANDCOMERCIAL USE IVD ONLY (*)
(*) Our biomarkers are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our biomarkers, you can visit here.